{
  "id": "LSB10483",
  "type": "CRS Report Type LSB",
  "typeId": "LSB",
  "number": "LSB10483",
  "active": true,
  "source": "CRSReports.Congress.gov",
  "versions": [
    {
      "source_dir": "crsreports.congress.gov",
      "title": "Testing, Testing, (Phase) 1-2-3: Legal Considerations for Clinical Trials of Potential COVID-19 Vaccines",
      "retrieved": "2020-09-07T12:22:53.832248",
      "id": "LSB10483_1_2020-06-02",
      "formats": [
        {
          "filename": "files/2020-06-02_LSB10483_4fbaea2647132b78f5f52a55701c84fc5e06e1f6.pdf",
          "format": "PDF",
          "url": "https://crsreports.congress.gov/product/pdf/LSB/LSB10483/1",
          "sha1": "4fbaea2647132b78f5f52a55701c84fc5e06e1f6"
        },
        {
          "format": "HTML",
          "filename": "files/2020-06-02_LSB10483_4fbaea2647132b78f5f52a55701c84fc5e06e1f6.html"
        }
      ],
      "date": "2020-06-02",
      "summary": null,
      "source": "CRSReports.Congress.gov",
      "typeId": "LSB",
      "active": true,
      "sourceLink": "https://crsreports.congress.gov/product/details?prodcode=LSB10483",
      "type": "CRS Report Type LSB"
    }
  ],
  "topics": []
}